Medicament for treating hepatitis B and preparation method

Abstract

The invention relates to a medicament (hepatitis B kangtai pills) for treating hepatitis B. The medicament is easily taken water pills prepared from the Chinese medicaments such as parasitic loranthus, piece turmeric, fructus kochiae, phyllanthus emblica, amomum tsao-ko, coptis chinensis, isatis root, abrus herb, oriental wormwood, emilia sonchifolia, polygonum cuspidatum, cyrtomium fortunei, cantharides, eclipta alba, cordyceps sinensis, astragalus mongholicus, aloe barbadensis, heterophylly falsestarwort root, subprostrate sophora, Chinese angelica, licorice root and the like in a certain ratio. The medicament can effectively protect the liver, inhibit viruses, has a remarkable curative effect after short-term administration, can promote HBsAg, HBeAg and Anti-HBc positive, HBsAg, HBeAb and HBcAb-positive and HBV test to be converted into negative or normal, lighten or vanish symptom, has the effective rate of 98 percent and the cure rate of over 93 percent, and is an effective medicament for treating the hepatitis B at present.

Description

Technical field: [0001] The invention is a pure traditional Chinese medicine water pill for treating hepatitis B, which belongs to the technical field of traditional Chinese medicine preparation and preparation methods. Background technique: [0002] Hepatitis B, the full name of viral hepatitis B, is an infectious disease caused by hepatitis B virus ((HBV). The incidence rate in developing countries is relatively high. According to statistics, about 120 million hepatitis B patients and hepatitis B virus carriers in my country, most of them Asymptomatic, 1 / 3 of which have clinical manifestations of liver damage. At present, there are about 50 million hepatitis B patients in my country. Due to the slow onset, subclinical and chronic types are more common. Patients with persistent positive HbsAg in the anicteric type are prone to chronicity The disease is mainly transmitted through blood, mother-infant and sexual contact. At present, the application of hepatitis B vaccine is onl...

AI Technical Summary

Problems solved by technology

[0006] 3. Chronic persistent hepatitis and asymptomatic HbsAg carriers can be infected with HBV when the body’s immune function is low, and cannot produce an effective immune response, causing slight or no liver cell damage

[0009] Currently, there is no specific drug for the treatment of hepatitis B. Drugs and interferon interventions for anti-virus, immune regulation, blood circulation, anti-fibrosis, and liver cell regeneration are mostly used.